FDA 483 - Merck KGaA - July 02, 2009

An FDA inspection of Merck KGaA, a medical device manufacturer in Darmstadt, Germany, revealed significant deficiencies in their quality system. Observations included failures to properly document nonconforming products, incomplete employee training records, and illegible quality processing records. These issues indicate a lack of adherence to established procedures and good documentation practices.